Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Financials
Pharma
Novartis gears up for key expansions of 3 cancer drugs
Pluvicto, Ksiqali and Scemblix have key new indications lined up for them in earlier treatment settings. But they all slightly disappointed in Q1.
Angus Liu
Apr 23, 2024 3:37pm
Novartis nominates ex-BMS chief Caforio as its next chair
Apr 23, 2024 2:44am
Amgen CEO nabs pay raise thanks to Horizon deal
Apr 18, 2024 5:08pm
Coherus lays off 30% of employees amid new 'sharpened focus'
Mar 13, 2024 6:10pm
Legend CEO offers preview of high-stakes FDA adcomm for Carvykti
Mar 11, 2024 1:29pm
Bayer CEO tables split-up, begins 'full-scale effort' for pharma
Mar 5, 2024 10:17am